Published Date:2022-05-24 Original Link:https://www.onenessbio.com/en/news_detail166_2.htm No 2 Date of announcement 2022/05/24 Time of announcement 19:09:21 Subject By-election of one director of the board in 2022 shareholders’ meeting To which item it meets paragraph 6 Date of events 2022/05/24 Statement Date of occurrence of the change:2022/05/24 Elected or changed position (Please enter institutional director, institutional supervisor, independent...Read More
Published Date:2022-05-24 Original Link:https://www.onenessbio.com/en/news_detail165_2.htm No 1 Date of announcement 2022/05/24 Time of announcement 19:02:49 Subject Oneness announce the important resolutions of the 2022 Annual General Shareholders’ Meeting To which item it meets paragraph 18 Date of events 2022/05/24 Statement Date of the shareholders’ meeting:2022/05/24 Important resolutions I.Profit distribution/deficit compensation:Approved the 2021 deficit compensation proposal. Important...Read More
Published Date:2022-05-11 Original Link:https://www.onenessbio.com/en/news_detail164_2.htm No 1 Date of announcement 2022/05/11 Time of announcement 17:37:30 Subject The Company’s 2022Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2022/05/11 Statement Date of the board of directors submitted or approved:2022/05/11 Date of the audit committee...Read More
Published Date:2022-05-02 Original Link:https://www.onenessbio.com/en/news_detail163_2.htm No 1 Date of announcement 2022/05/02 Time of announcement 20:10:48 Subject Oneness received the notification by the international CRO on the unblinded data of FB825 Phase 2a study in moderate-to-severe atopic dermatitis in the U.S. To which item it meets paragraph 10 Date of events 2022/05/02 Statement Product:FB825 Anti-CεmX monoclonal antibody...Read More
Published Date:2022-04-18 Original Link:https://www.onenessbio.com/en/news_detail160_3.htm No 1 Date of announcement 2022/04/18 Time of announcement 19:11:58 Subject The Food and Drug Administration–Philippines (PFDA) has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 10 Date of events 2022/04/18 Statement Product:ON101 Diabetic foot ulcer new drug Mass production date:NA...Read More
Published Date:2022-04-11 Original Link:https://www.onenessbio.com/en/news_detail159_3.htm No 1 Date of announcement 2022/04/11 Time of announcement 17:24:47 Subject Oneness Biotech has been invited to present at the “11th Taiwan CEO Week” online investor’s conference co-organized by TWSE and QIC To which item it meets paragraph 12 Date of events 2022/04/13 Statement Date of institutional investor conference:2022/04/13~2022/04/14 Time of...Read More
Published Date:2022-04-08 Original Link:https://www.onenessbio.com/en/news_detail158_3.htm No 2 Date of announcement 2022/04/08 Time of announcement 18:13:27 Subject Oneness Biotech Co., Ltd. receives ISO13485 Medical Devices Quality Management System Certificate. To which item it meets paragraph 53 Date of events 2022/04/08 Statement Date of occurrence of the event:2022/04/08 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please...Read More
Published Date:2022-04-08 Original Link:https://www.onenessbio.com/en/news_detail157_3.htm No 1 Date of announcement 2022/04/08 Time of announcement 17:08:39 Subject Oneness re-announces the Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2022. (Method of convening the meeting: hybrid shareholders’ meeting) To which item it meets paragraph 17 Date of events 2022/04/08 Statement Date of the board of...Read More
